Related references
Note: Only part of the references are listed.The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
Naga Chalasani et al.
HEPATOLOGY (2018)
Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017Part 1: Definition, risk factors and assessment
Vincent Wai-Sun Wong et al.
JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY (2018)
Effects of Diabetes and Glycemic Control on Risk of Hepatocellular Carcinoma After Seroclearance of Hepatitis B Surface Antigen
Terry Cheuk-Fung Yip et al.
CLINICAL GASTROENTEROLOGY AND HEPATOLOGY (2018)
Chronic Hepatitis B Increases Liver-Related Mortality of Patients With Acute Hepatitis E: A Territorywide Cohort Study From 2000 to 2016
Jimmy Che-To Lai et al.
CLINICAL INFECTIOUS DISEASES (2018)
Chronic kidney disease progression in patients with chronic hepatitis B on tenofovir, entecavir, or no treatment
Grace Lai-Hung Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2018)
On-Treatment Improvement of MELD Score Reduces Death and Hepatic Events in Patients With Hepatitis B-Related Cirrhosis
Terry Cheuk-Fung Yip et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2018)
Glycemic Targets: Standards of Medical Care in Diabetes-2018
DIABETES CARE (2018)
Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2018
DIABETES CARE (2018)
Antiplatelet Therapy and the Risk of Hepatocellular Carcinoma in Chronic Hepatitis B Patients on Antiviral Treatment
Minjong Lee et al.
HEPATOLOGY (2017)
Impact of age and gender on risk of hepatocellular carcinoma after hepatitis B surface antigen seroclearance
Terry Cheuk-Fung Yip et al.
JOURNAL OF HEPATOLOGY (2017)
Practical recommendations for reporting Fine-Gray model analyses for competing risk data
Peter C. Austin et al.
STATISTICS IN MEDICINE (2017)
Statins reduce the risk of liver decompensation and death in chronic viral hepatitis: a propensity score weighted landmark analysis
J. C. -T. Wong et al.
ALIMENTARY PHARMACOLOGY & THERAPEUTICS (2017)
Management of Nonalcoholic Fatty Liver Disease in Patients With Type 2 Diabetes: A Call to Action
Fernando Bril et al.
DIABETES CARE (2017)
Statin and the risk of hepatocellular carcinoma and death in a hospital-based hepatitis B-infected population: A propensity score landmark analysis
John Chen Hsiang et al.
JOURNAL OF HEPATOLOGY (2015)
Nonalcoholic fatty liver disease
Elizabeth M. Brunt et al.
NATURE REVIEWS DISEASE PRIMERS (2015)
Additive effects of blood glucose lowering drugs, statins and renin-angiotensin system blockers on all-site cancer risk in patients with type 2 diabetes
Alice P. S. Kong et al.
BMC MEDICINE (2014)
Anti-Diabetic Medications and the Risk of Hepatocellular Cancer: A Systematic Review and Meta-Analysis
Siddharth Singh et al.
AMERICAN JOURNAL OF GASTROENTEROLOGY (2013)
Enhancers and attenuators of risk associations of chronic hepatitis B virus infection with hepatocellular carcinoma in type 2 diabetes
Xilin Yang et al.
ENDOCRINE-RELATED CANCER (2013)
Statins Are Associated With a Reduced Risk of Hepatocellular Cancer: A Systematic Review and Meta-analysis
Siddharth Singh et al.
GASTROENTEROLOGY (2013)
Metformin decreases hepatocellular carcinoma risk in a dose-dependent manner: population-based and in vitro studies
Hsiao-Ping Chen et al.
GUT (2013)
Entecavir Treatment Reduces Hepatic Events and Deaths in Chronic Hepatitis B Patients With Liver Cirrhosis
Grace Lai-Hung Wong et al.
HEPATOLOGY (2013)
Nonalcoholic Fatty Liver: A Possible New Target for Type 2 Diabetes Prevention and Treatment
Barbara Fruci et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2013)
Obesity, insulin resistance, NASH and hepatocellular carcinoma
Jun Yu et al.
SEMINARS IN CANCER BIOLOGY (2013)
PPARgamma inhibits hepatocellular carcinoma metastases in vitro and in mice
B. Shen et al.
BRITISH JOURNAL OF CANCER (2012)
Association of thiazolidinediones with liver cancer and colorectal cancer in type 2 diabetes mellitus
Chia-Hsuin Chang et al.
HEPATOLOGY (2012)
Low Glycated Hemoglobin and Liver Disease in the US Population
Andrea L. Christman et al.
DIABETES CARE (2011)
Association of Diabetes Duration and Diabetes Treatment With the Risk of Hepatocellular Carcinoma
Manal M. Hassan et al.
CANCER (2010)
Associations of Hyperglycemia and Insulin Usage With the Risk of Cancer in Type 2 Diabetes: The Hong Kong Diabetes Registry
Xilin Yang et al.
DIABETES (2010)
Disease progression of non-alcoholic fatty liver disease: a prospective study with paired liver biopsies at 3 years
Vincent Wai-Sun Wong et al.
GUT (2010)
Mechanisms by which thiazolidinediones induce anti-cancer effects in cancers in digestive organs
Toshikatsu Okumura
JOURNAL OF GASTROENTEROLOGY (2010)
Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2009)
Metabolic syndrome increases the risk of liver cirrhosis in chronic hepatitis B
G. L-H Wong et al.
GUT (2009)
A comparative study of survival models for breast cancer prognostication based on microarray data: does a single gene beat them all?
B. Haibe-Kains et al.
BIOINFORMATICS (2008)
Metabolic factors and risk of hepatocellular carcinoma by chronic hepatitis B/C infection: A follow-up study in Taiwan
Chi-Ling Chen et al.
GASTROENTEROLOGY (2008)
Genotype C hepatitis B virus infection is associated with an increased risk of hepatocellular carcinoma
HLY Chan et al.
GUT (2004)
Effects of rosiglitazone and metformin on liver fat content, hepatic insulin resistance, insulin clearance, and gene expression in adipose tissue in patients with type 2 diabetes
M Tiikkainen et al.
DIABETES (2004)
Pioglitazone reduces hepatic fat content and augments splanchnic glucose uptake in patients with type 2 diabetes
M Bajaj et al.
DIABETES (2003)
Risk factors for hepatocellular carcinoma: Synergism of alcohol with viral hepatitis and diabetes mellitus
MM Hassan et al.
HEPATOLOGY (2002)
Share Paper
